Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Assessment of Olfactory Dysfunction and Impact on Quality of Life in SARS CoV-2 (COVID-19)Infection Using the UPSIT, eQOD and SNOT-22 Questionnaires: A Prospective Observational Cohort Study

NCT04466982 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT04466982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04466982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Assessment of Olfactory Dysfunction and Impact on Quality of Life in SARS CoV-2 (COVID-19)Infection Using the UPSIT, eQOD and SNOT-22 Questionnaires: A Prospective Observational Cohort Study
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
July 2, 2020
Completion date
March 30, 2023
Enrollment
81 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anosmia, covid19, microsomia, olfactory disorder, quality of life, sars-cov-2, smell disorder